secwatch.observer — SEC 8-K summary
======================================

Issuer:     TANDEM DIABETES CARE INC (TNDM)
CIK:        0001438133
Form:       8-K
Filed at:   2023-11-13T23:59:59+00:00
Accession:  0001438133-23-000210
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Tandem Diabetes COO David Berger to step down Dec 31, 2023
----------------------------------------------------------

- David B. Berger, EVP and COO, will leave his role effective December 31, 2023.
- Berger oversaw clinical, quality, regulatory, legal, customer support, and operations.
- He will provide transition advisory services to the company through 2024.
- No successor named; terms of advisory agreement to be disclosed in a later filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1438133/000143813323000210/0001438133-23-000210-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1438133/000143813323000210/tndm-20231107.htm
  HTML page:      https://secwatch.observer/filing/0001438133-23-000210

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer